HY-035

N/A

Report date: 2025/01/08 14:53:51

Base Information

Drug NameHY-035
Drug Alias NameHY-035HY035
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionAnti-CD7Cell replacements
TargetsT-cell antigen CD7
Therapy Area/IndicationsLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJuventas Cell Therapy Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJuventas Cell Therapy Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, T-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A